Stoke Therapeutics, Inc. (STOK) — SC 13G/A Filings
All SC 13G/A filings from Stoke Therapeutics, Inc.. Browse 9 SC 13G/A reports with AI-powered summaries and risk analysis.
SC 13G/A Filings (9)
- SC 13G/A Filing — Nov 14, 2024
- SC 13G/A Filing — Nov 14, 2024
- SC 13G/A Filing — Nov 12, 2024
- SC 13G/A Filing — Nov 4, 2024
- SC 13G/A Filing — Feb 26, 2024
- SC 13G/A Filing — Feb 14, 2024
- SC 13G/A Filing — Feb 14, 2024
-
FMR LLC & Abigail Johnson Slash STOK Stake to 0.011%
— Feb 9, 2024 Risk: medium
FMR LLC, a major investment management firm, and its Chair and CEO, Abigail P. Johnson, have significantly reduced their beneficial ownership in Stoke Therapeut -
Morgan Stanley Amends Stoke Therapeutics Stake as of Dec 31, 2023
— Feb 9, 2024 Risk: low
Morgan Stanley filed an amended SC 13G/A on February 9, 2024, indicating a change in its beneficial ownership of Stoke Therapeutics, Inc. common stock as of Dec
Popular Companies
AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX